Drugs / MDPK67b
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05580107 | Aug 2021 → Jun 2024 | prostate cancer | Med Discovery SA | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04839120 Comparator | Feb → Jun 2017 | prostate neoplasm | Med Discovery SA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDPK67b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04839120 ↗ |
| Action | Inhibit | “KLK Inhibitor MDPK67b” NCT04839120 ↗ |
| Route | Intravenous | “ascending intravenous doses of MDPK67b” NCT04839120 ↗ |